WDR12/RAC1 Axis Promoted Proliferation and Anti-apoptosis in Colorectal Cancer Cells

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2024 Feb 11

PMID 38341833

Authors

Su Wen

Xueqing Huang

Liping Xiong

Hao Zeng

Shuang Wu

Kangli An

Jing Bai

Zhipeng Zhou

Tiejun Yin

Affiliations

Soon will be listed here.

Abstract

Background: WD repeat domain 12 (WDR12) plays a crucial role in the ribosome biogenesis pathway. However, its biological function in colorectal cancer (CRC) remains poorly understood. Therefore, this study aims to investigate the roles of WDR12 in the occurrence and progression of CRC, as well as its underlying mechanisms.

Methods: The expression of WDR12 was assessed through The Cancer Genome Atlas (TCGA) and the Human Protein Atlas (HPA) database. Functional experiments including Celigo assay, MTT assay, and Caspase-3/7 assay were conducted to validate the role of WDR12 in the malignant progression of CRC. Additionally, mRNA chip-sequencing and ingenuity pathway analysis (IPA) were performed to identify the molecular mechanism.

Results: WDR12 expression was significantly upregulated in CRC tissues compared to normal colorectal tissues. Knockdown of WDR12 reduced proliferation and promoted apoptosis of CRC cell lines in vitro and in vivo experiments. Furthermore, WDR12 expression had a significantly inverse association with diseases and functions, including cancer, cell cycle, DNA replication, recombination, cellular growth, proliferation and repair, as revealed by IPA analysis of mRNA chip-sequencing data. Moreover, the activation of cell cycle checkpoint kinases proteins in the cell cycle checkpoint control signaling pathway was enriched in the WDR12 knockdown CRC cell lines. Additionally, downregulation of rac family small GTPase 1 (RAC1) occurred upon WDR12 knockdown, thereby facilitating the proliferation and anti-apoptosis of CRC cells.

Conclusion: Our study demonstrates that the WDR12/RAC1 axis promotes tumor progression in CRC. Therefore, WDR12 may serve as a novel oncogene and a potential target for individualized therapy in CRC. These findings provide an experimental foundation for the clinical development of drugs targeting the WDR12/RAC1 axis.

Citing Articles

Roles of WDR12 and MRTO4 genes in colorectal cancer.

Luo H Medicine (Baltimore). 2025; 103(52):e41048.

PMID: 39969382 PMC: 11688001. DOI: 10.1097/MD.0000000000041048.

Correlation analysis of serum Rac1 level with asthma control, airway inflammatory response and lung function in asthmatic children.

Fu H, Gao Y BMC Pulm Med. 2024; 24(1):455.

PMID: 39285415 PMC: 11406832. DOI: 10.1186/s12890-024-03266-5.

References

Keum N, Giovannucci E . Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019; 16(12):713-732. DOI: 10.1038/s41575-019-0189-8. View

Grothey A, Fakih M, Tabernero J . Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines. Ann Oncol. 2021; 32(8):959-967. DOI: 10.1016/j.annonc.2021.03.206. View

Tiwari A, Saraf S, Verma A, Panda P, Jain S . Novel targeting approaches and signaling pathways of colorectal cancer: An insight. World J Gastroenterol. 2018; 24(39):4428-4435. PMC: 6196338. DOI: 10.3748/wjg.v24.i39.4428. View

Silva V, Santos L, Dias R, Quadros C, Bezerra D . Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells. Cancer Commun (Lond). 2021; 41(12):1275-1313. PMC: 8696218. DOI: 10.1002/cac2.12235. View

Piawah S, Venook A . Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019; 125(23):4139-4147. DOI: 10.1002/cncr.32163. View

Nal B, Mohr E, Da Silva M, Tagett R, Navarro C, Carroll P . Wdr12, a mouse gene encoding a novel WD-Repeat Protein with a notchless-like amino-terminal domain. Genomics. 2002; 79(1):77-86. DOI: 10.1006/geno.2001.6682. View

Neer E, Schmidt C, Nambudripad R, Smith T . The ancient regulatory-protein family of WD-repeat proteins. Nature. 1994; 371(6495):297-300. DOI: 10.1038/371297a0. View

Smith T, Gaitatzes C, Saxena K, Neer E . The WD repeat: a common architecture for diverse functions. Trends Biochem Sci. 1999; 24(5):181-5. DOI: 10.1016/s0968-0004(99)01384-5. View

Romes E, Sobhany M, Stanley R . The Crystal Structure of the Ubiquitin-like Domain of Ribosome Assembly Factor Ytm1 and Characterization of Its Interaction with the AAA-ATPase Midasin. J Biol Chem. 2015; 291(2):882-93. PMC: 4705406. DOI: 10.1074/jbc.M115.693259. View

10.

Lewinska A, Bednarz D, Adamczyk-Grochala J, Wnuk M . Phytochemical-induced nucleolar stress results in the inhibition of breast cancer cell proliferation. Redox Biol. 2017; 12:469-482. PMC: 5362140. DOI: 10.1016/j.redox.2017.03.014. View

11.

Li J, Chen C, Chen W, Zhao L, Xu X, Li Y . Integrative genomic analyses identify WDR12 as a novel oncogene involved in glioblastoma. J Cell Physiol. 2020; 235(10):7344-7355. DOI: 10.1002/jcp.29635. View

12.

Yin Y, Zhou L, Zhan R, Zhang Q, Li M . Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation. Cancer Manag Res. 2018; 10:3985-3993. PMC: 6166768. DOI: 10.2147/CMAR.S176268. View

13.

Sun Y, Liu M, Yang B, Li B, Lu J . Role of siRNA silencing of MMP-2 gene on invasion and growth of laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2008; 265(11):1385-91. DOI: 10.1007/s00405-008-0684-y. View

14.

Barros P, Lam E, Jordan P, Matos P . Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters. Nucleic Acids Res. 2012; 40(16):7776-87. PMC: 3439931. DOI: 10.1093/nar/gks571. View

15.

Myant K, Cammareri P, McGhee E, Ridgway R, Huels D, Cordero J . ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell. 2013; 12(6):761-73. PMC: 3690525. DOI: 10.1016/j.stem.2013.04.006. View

16.

Rohrmoser M, Holzel M, Grimm T, Malamoussi A, Harasim T, Orban M . Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit. Mol Cell Biol. 2007; 27(10):3682-94. PMC: 1899993. DOI: 10.1128/MCB.00172-07. View

17.

Rose B, Force T, Wang Y . Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev. 2010; 90(4):1507-46. PMC: 3808831. DOI: 10.1152/physrev.00054.2009. View

18.

Pitts T, Davis S, Eckhardt S, Bradshaw-Pierce E . Targeting nuclear kinases in cancer: development of cell cycle kinase inhibitors. Pharmacol Ther. 2013; 142(2):258-69. DOI: 10.1016/j.pharmthera.2013.12.010. View

19.

Riese U, Dahse R, Fiedler W, Theuer C, Koscielny S, Ernst G . Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer. Int J Mol Med. 1999; 4(1):61-5. DOI: 10.3892/ijmm.4.1.61. View

20.

Alhejaily A, Day A, Feilotter H, Baetz T, LeBrun D . Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome. Clin Cancer Res. 2014; 20(6):1676-86. DOI: 10.1158/1078-0432.CCR-13-2175. View